TheEdgeResearch
Home / Stocks / SSSGY

Sartorius AG (SSSGY)

OTC Healthcare Medical - Instruments & Supplies
$43.93 ▲ +0.00%
Market Cap
$15.17B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Beta
1.36
52-Wk Range
37.87-52.97
CEO
Michael Grosse
Country
DE
Currency
USD

Sartorius AG operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Göttingen, NI, DE. The stock last traded at $43.93, up 0.00% on the session, giving a market capitalisation of $15.17B. On trailing twelve-month figures it carries a trailing P/E of 70.89, a net margin of 6.0%. Its beta of 1.36 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
70.89
Price / Sales
4.22
Price / Book
5.27
EV / EBITDA
17.73
Gross margin
45.4%
Operating margin
17.8%
Net margin
6.0%
Return on equity
—
Debt / equity
1.33
Current ratio
1.07
Dividend yield
0.3%
Payout ratio
23.3%
Company profile
Exchange
Other OTC
Employees
14,042
IPO date
2021-01-19
Headquarters
Göttingen, NI, DE
About Sartorius AG

Sartorius AG, founded in Göttingen, Germany in 1870, is a global supplier of advanced bioprocess solutions, laboratory products, and associated services. The company's diverse portfolio encompasses several critical areas: For biosensing and detection, it provides biosensors, compliance instruments, system software, label-free detection technologies, and SPR systems. In cell analysis, Sartorius offers live-cell analysis platforms, flow cytometry systems, and specialized cell analysis reagents and consumables. Its media and reagent segment includes a wide array of formulations for antibody and recombinant protein production, viral vaccines, regenerative medicine, and stem cell cultivation, along with downstream buffers, microcarriers, strong acids, bases, alcohols, and detergents. The company manufactures various bioreactor systems, from multi-parallel and benchtop units to single-use, stainless steel, cell culture, and microbial bioreactors, all supported by dedicated software applications. Its extensive filtration product line features membranes, blotting products, filter papers, and glass and quartz microfibre products, alongside a comprehensive range of filtration devices for ultrafiltration, sterile filtration, harvesting, analytical and diagnostic sample preparation, particle analysis, pharmaceutical applications, protein/DNA concentration, venting, clarification, and membrane chromatography. Sartorius also delivers solutions for process filtration, process chromatography, fluid management, and cutting-edge process analytical technology with data analytics. Complementary laboratory equipment includes industrial microbiology systems, water purification units, precision weighing and pipetting/dispensing systems, OEM components, and centrifuges. Beyond its products, Sartorius provides essential services such as bioprocess development and engineering, protein expression system optimization, media and process development, comprehensive testing, instrument support, and validation. These offerings primarily serve the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industrial sectors across the globe.

Comparable companies

Sartorius AG is most often compared with the following Healthcare names:

AZTABIOBLFSBRKRMRVIQGENRGENTCGGYTECHTMO
More research on SSSGY
SSSGY technical analysis SSSGY TheEdge Score Compare against peers
Open full interactive analysis & DCF →